Sabino Roberto Di Paola

Sabino Roberto Di Paola discloses dealings in Tetra Bio-Pharma Inc. to SEDI. In total, 6 filings cover trades dated from 16 November 2016 to 24 May 2017.

On the market, this insider has only sold: 4 sales, €2.0M in total. Besides market trades, the filings include 1 share grant and 1 option exercise. 2017 to date brings no purchases and 1 sale.

Most recently, on 25 May 2017, the filings show an open-market sale worth €91k in Tetra Bio-Pharma Inc. Filings reach the SEDI feed a median of 1 day after the trade. That lag is the time during which only the insider knows about the trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.